SANGAMO THERAPEUTICS, INC - Common Stock (SGMO)

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class
Equity / Common Stock
Shares outstanding
294,683,714
Total 13F shares
48,505,425
Share change
+1,375,207
Total reported value
$523,162,567
Put/Call ratio
3%
Price per share
$10.78
Number of holders
154
Value change
+$6,234,502
Number of buys
72
Number of sells
63

Institutional Holders of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) as of Q3 2014

As of 30 Sep 2014 SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) had 154 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 48,505,425 shares of stock of the company.
Largest 10 holders included FMR LLC, WASATCH ADVISORS INC, ADAGE CAPITAL PARTNERS GP LLC, State Street Corp, BlackRock Fund Advisors, FRONTIER CAPITAL MANAGEMENT CO LLC, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., JENNISON ASSOCIATES LLC, and JANUS CAPITAL MANAGEMENT LLC.
This table shows 154 institutional shareholders of the security as of 30 Sep 2014.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.